Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

66.16
Delayed Data
As of Jun 23
 +0.14 / +0.21%
Today’s Change
55.10
Today|||52-Week Range
66.80
+12.38%
Year-to-Date
On Not Talking About the 'Market'; Darth Vader, Meet Amazon: Jim Cramer's Best Blog
Jun 23 / TheStreet.com - Paid Partner Content
Why You Should Add Novo Nordisk Stock to Your Portfolio
Jun 22 / Zacks.com - Paid Partner Content
Could Merck and Leap union be the one for Keytruda?
Jun 23 / TheStreet.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
Jun 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod
Jun 23 / Zacks.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Momentum?
Jun 22 / Zacks.com - Paid Partner Content
Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger
Jun 22 / Zacks.com - Paid Partner Content
Ligand Gets Milestone Payment on Partner Drug FDA Approval
Jun 21 / Zacks.com - Paid Partner Content
Merck's Powerful Rally Is Coming So Back Up the Truck
Jun 22 / TheStreet.com - Paid Partner Content
VBI Vaccines Just Took a Major Step Forward in Its HBV Program
Jun 21 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close66.02
Today’s open66.04
Day’s range65.84 - 66.39
Volume14,093,453
Average volume (3 months)9,234,779
Market cap$180.6B
Dividend yield2.84%
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+1.53%
Earnings growth (next 5 years)+6.20%
Revenue growth (last year)+1.86%
P/E ratio42.1
Price/Sales4.15
Price/Book4.53

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.11+0.32%
NVSNovartis0.000.00%
SNYSanofi-0.28-0.56%
ABBVAbbVie-0.54-0.74%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$0.87
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts